审稿速度:1.0 偏重的研究方向:糖尿病 经验分享:期刊转投,副主编和独立审稿人各一个审稿。
23.11.13 submit
23.11.15 with editor
23.11.16 under review
23.11.17 under review(审稿人接受审稿)
23.12.17 under review(第一个审稿意见)
23.12.19 under review(第二个审稿人)
24.1.19 required reviews completed(第二个审稿意见)
24.1.21 decision in process
24.1.22 major revision
24.2.2 revision submit
24.2.3 with editor
24.2.4 under review
24.2.5 required reviews completed / decision in process
24.2.6 accept
Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4.
Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25.
Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. 我们总结下来,用基础研究的方法做临床,就基本没问题。
审稿速度:6.0 | 投稿命中率:5.0
偏重的研究方向:甲状腺肿瘤
经验分享:去年十一月投的稿件了,期间有一位审稿人接受,最近又变成了最原始的状态,什么消息也没有,打算催稿了
5
审稿速度:2.0 | 投稿命中率:50.0
经验分享:在投
3
审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向:甲状腺
经验分享:12 月投稿,1 月返修,2 月发表。最后确认时可以选择非 oa,不用版面费,编辑人也很好,总体而言挺推荐的。
1
投稿命中率:25.0
经验分享:在投
0
求该期刊的参考文献格式,谢谢!
65
偏重的研究方向:甲状腺
经验分享:2024.1.25 editor appointed
17
审稿速度:1.0
偏重的研究方向:糖尿病
经验分享:期刊转投,副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review(审稿人接受审稿) 23.12.17 under review(第一个审稿意见) 23.12.19 under review(第二个审稿人) 24.1.19 required reviews completed(第二个审稿意见) 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept
42
审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向:内分泌
经验分享:感觉主编权力挺大的,人也很好,不刁钻
31
我现在已经投稿了快60天,一直显示Under Review,老天啊
81
这个杂志分数不高,老板与主编还认识,几乎成为我们的实验室专业户了。
Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4.
Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25.
Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44.
我们总结下来,用基础研究的方法做临床,就基本没问题。
313